FFCP PHASE1:Hg19::chr15:68117826..68117829,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=390598 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=21326 | |||
|TSSclassifier=strong | |||
|UniProt=G3V5H7 | |||
|association_with_transcript=-24bp_to_ENST00000554054_5end | |||
|coexpression_cluster_id=C321 | |||
|description=CAGE_peak_9_at_SKOR1_5end | |||
|id=chr15:68117826..68117829,+ | |||
|ontology_enrichment_celltype=CL:0000242!5.04e-34!2;CL:0000214!2.62e-23!3;CL:0000312!1.60e-14!5;CL:0000240!2.45e-12!6;CL:0000311!2.45e-12!6;CL:0000079!2.45e-12!6;CL:0000237!2.45e-12!6;CL:0000036!2.45e-12!6;CL:0000357!2.45e-12!6;CL:0000114!2.45e-12!6;CL:0000039!9.89e-11!7;CL:0000586!9.89e-11!7;CL:0000362!1.35e-09!8;CL:0000153!1.04e-08!9;CL:0000447!1.04e-08!9 | |||
|ontology_enrichment_celltype_v019=CL:0000214;2.39e-66;3!CL:0000153;2.62e-23;9!CL:0000447;2.62e-23;9!CL:0000327;1.22e-14;15!CL:0000499;1.52e-08;28!CL:0002078;2.32e-07;45 | |||
|ontology_enrichment_celltype_v019_2=CL:0000214,2.39e-66,3;CL:0000153,2.62e-23,9;CL:0000447,2.62e-23,9;CL:0000327,1.22e-14,15;CL:0000499,1.52e-08,28;CL:0000151,5.81e-07,36 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019=DOID:1115;2.29e-11;20 | |||
|ontology_enrichment_disease_v019_2=DOID:1115,2.29e-11,20 | |||
|ontology_enrichment_uberon=UBERON:0006915!2.62e-23!3;UBERON:0002018!2.62e-23!3;UBERON:0002217!2.62e-23!3;UBERON:0007616!2.62e-23!3;UBERON:0004905!1.40e-14!5;UBERON:0000982!1.40e-14!5;UBERON:0004770!1.40e-14!5;UBERON:0000473!1.47e-09!8;UBERON:0003135!2.63e-07!11;UBERON:0004457!7.48e-07!12;UBERON:0000042!7.48e-07!12 | |||
|ontology_enrichment_uberon_v019=UBERON:0006915;2.39e-66;3!UBERON:0007616;2.39e-66;3!UBERON:0002217;2.39e-66;3!UBERON:0002018;2.39e-66;3!UBERON:0004905;5.22e-26;8!UBERON:0000982;5.22e-26;8!UBERON:0004770;5.22e-26;8!UBERON:0004457;2.62e-23;9!UBERON:0000042;2.62e-23;9!UBERON:0000486;6.76e-18;12!UBERON:0006914;2.15e-09;25 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0006915,2.39e-66,3;UBERON:0007616,2.39e-66,3;UBERON:0002217,2.39e-66,3;UBERON:0002018,2.39e-66,3;UBERON:0004905,5.22e-26,8;UBERON:0000982,5.22e-26,8;UBERON:0004770,5.22e-26,8;UBERON:0004457,6.76e-18,12;UBERON:0000042,6.76e-18,12;UBERON:0006914,2.15e-09,25 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.468334905806882,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.83988811947732,0,0,0,0,0,0,0,0,0,0,0,0.0918948995348449,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p9@SKOR1 | |||
}} |
Revision as of 00:14, 12 January 2014
Short description: | p9@SKOR1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_9_at_SKOR1_5end |
Coexpression cluster: | C321_synovial_anaplastic_maxillary_glassy_keratoacanthoma_rhabdomyosarcoma_small |
Association with transcript: | -24bp_to_ENST00000554054_5end |
EntrezGene: | SKOR1 |
HGNC: | 21326 |
UniProt: | G3V5H7 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
synovial cell | 2.39e-66 | 3 |
GAG secreting cell | 2.62e-23 | 9 |
carbohydrate secreting cell | 2.62e-23 | 9 |
extracellular matrix secreting cell | 1.22e-14 | 15 |
stromal cell | 1.52e-08 | 28 |
secretory cell | 5.81e-07 | 36 |
Ontology term | p-value | n |
---|---|---|
stratified squamous epithelium | 2.39e-66 | 3 |
layer of synovial tissue | 2.39e-66 | 3 |
synovial joint | 2.39e-66 | 3 |
synovial membrane of synovial joint | 2.39e-66 | 3 |
articulation | 5.22e-26 | 8 |
skeletal joint | 5.22e-26 | 8 |
articular system | 5.22e-26 | 8 |
cavity lining | 6.76e-18 | 12 |
serous membrane | 6.76e-18 | 12 |
squamous epithelium | 2.15e-09 | 25 |
Ontology term | p-value | n |
---|---|---|
sarcoma | 2.29e-11 | 20 |